Non-high-density lipoprotein cholesterol and residual cardiorenal risk in statin-treated patients with type 2 diabetes mellitus
Despite achieving low-density lipoprotein cholesterol (LDL-C) targets with statin therapy, patients with type 2 diabetes mellitus (T2DM) retain a high residual risk for cardiovascular and renal complications. Non-HDL cholesterol (non-HDL-C) captures the atherogenic burden of all apolipoprotein B-containing partic...